Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

The Medicines Company

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of The Medicines Company's 2013 cardiovasular sales performance.

The Medicines Company

Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe company. The company points out that its European summary of product characteristics (SmPC) lists data from APOLLO on primary and secondary endpoints, including exploratory cardiac endpoints - long term data from it ... Alnylam has three more RNAi

UK trumpets life sciences post-Brexit ‘sector deal’

UK trumpets life sciences post-Brexit ‘sector deal’ Other projects highlighted in the document include a $100m contract from The Medicines Company to test a cholesterol-lowering drug at the University of Oxford’s clinical trials unit, a £40m ... This ecosystem will deliver for everyone,” he added.

The Medicines Company strengthens board of directors

The Medicines Company strengthens board of directors He said: “ I am delighted to be joining The Medicines Company, especially at such an important time. ... Clive Meanwell, chief executive officer and director of The Medicines Company, said: “We are pleased to welcome someone of Paris’s caliber to

AZ gets EU green light for new antibiotic Zavicefta

AZ gets EU green light for new antibiotic Zavicefta The European Medicines Agency (EMA) cleared Zavicefta (ceftazidime and avibactam) for the treatment of serious Gram-negative bacterial infections requiring hospitalization. ... The Medicines Company also has a candidate called RPXZ7009 in phase III trials

Deal Watch May 2016

Deal Watch May 2016 The CRL refers to a manufacturing issue. ZS-9 was acquired when the company purchased ZS Pharma for $2.7bn. ... 911. The Medicines Company/ Chiesi. Product acquisition. Acquisition of cardiovascular assets Cleviprex, Kengreal and rights to Argatroban.

[ Previous 5 results ] 1 2 3 4 5 6 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics